<?xml version="1.0" encoding='utf-8'?>
<!DOCTYPE wml PUBLIC "-//WAPFORUM//DTD WML 1.1//EN" "http://www.wapforum.org/DTD/wml_1.1.xml">
<wml>
<card id="card1" title="Substrate reduction therapy - Page 3 - Wikipedia">
<p>
<a accesskey="1" href="page.php?w=substrate_reduction_therapy&amp;p=2">1.Previous</a><br />
<a accesskey="3" href="page.php?w=substrate_reduction_therapy&amp;p=4">3.Next</a>
</p>
<p>by one gene through its RNA and protein products. At each phase in the pathway, enzyme activity catalyzes a reaction in which a precursor molecule (the <a href="page.php?w=Substrate_%28biochemistry%29">substrate</a>) is transformed into its next intermediate state. Failure of the metabolic pathway leads to accumulation of the substrate, with possible harmful effects. Substrate reduction therapy addresses this failure by reducing the level of the substrate to a point where residual degradative activity is sufficient to prevent substrate accumulation.__TOC__</p><p>
<a accesskey="1" href="page.php?w=substrate_reduction_therapy&amp;p=2">1.Previous</a><br />
<a accesskey="3" href="page.php?w=substrate_reduction_therapy&amp;p=4">3.Next</a>
</p>

<do type="prev" label="Search">
        <go href="search.wml"/>
</do>

</card>
</wml>
